Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Inclusion body myositis.

Tawil R, Griggs RC.

Curr Opin Rheumatol. 2002 Nov;14(6):653-7. Review.

PMID:
12410086
[PubMed - indexed for MEDLINE]
2.
3.

Inclusion body myositis--a review.

Vogel H.

Adv Anat Pathol. 1998 May;5(3):164-9. Review.

PMID:
9868522
[PubMed - indexed for MEDLINE]
4.

Treatment of inclusion body myositis.

Cherin P.

Curr Opin Rheumatol. 1999 Nov;11(6):456-61. Review.

PMID:
10551668
[PubMed - indexed for MEDLINE]
5.

[New insights in pathogenesis and therapy of sporadic inclusion body myositis (s-IBM)].

Walter MC, Lochmüller H, Schlotter B, Reilich P, Müller-Felber W, Pongratz D.

Nervenarzt. 2001 Feb;72(2):117-21. Review. German.

PMID:
11256145
[PubMed - indexed for MEDLINE]
6.

Inclusion body myositis: old and new concepts.

Amato AA, Barohn RJ.

J Neurol Neurosurg Psychiatry. 2009 Nov;80(11):1186-93. doi: 10.1136/jnnp.2009.173823. Review.

PMID:
19864656
[PubMed - indexed for MEDLINE]
7.

Treatment of inclusion body myositis with cyclosporin-A or tacrolimus: successful long-term management in patients with earlier active disease and concomitant autoimmune features.

Quartuccio L, De Marchi G, Scott CA, Ferraccioli G, Beltrami CA, De Vita S.

Clin Exp Rheumatol. 2007 Mar-Apr;25(2):246-51.

PMID:
17543149
[PubMed - indexed for MEDLINE]
8.

Dermatomyositis with inclusion body myositis pathology.

Layzer R, Lee HS, Iverson D, Margeta M.

Muscle Nerve. 2009 Sep;40(3):469-71. doi: 10.1002/mus.21377.

PMID:
19623629
[PubMed - indexed for MEDLINE]
9.

Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease.

Askanas V, Engel WK.

J Neuropathol Exp Neurol. 2001 Jan;60(1):1-14. Review.

PMID:
11202170
[PubMed - indexed for MEDLINE]
10.

[Inclusion body myositis pathomechanism and therapy].

Váncsa A, Dankó K.

Orv Hetil. 2008 Jul 27;149(30):1413-8. doi: 10.1556/OH.2008.28070. Review. Hungarian.

PMID:
18621600
[PubMed - indexed for MEDLINE]
11.

Inflammatory myopathy with cytochrome oxidase negative muscle fibers: methotrexate treatment.

Levine TD, Pestronk A.

Muscle Nerve. 1998 Dec;21(12):1724-8.

PMID:
9843075
[PubMed - indexed for MEDLINE]
12.

Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis.

Askanas V, Engel WK.

Curr Opin Rheumatol. 1998 Nov;10(6):530-42. Review.

PMID:
9812213
[PubMed - indexed for MEDLINE]
13.

Sporadic inclusion body myositis: counts of different types of abnormal fibers.

Pruitt JN 2nd, Showalter CJ, Engel AG.

Ann Neurol. 1996 Jan;39(1):139-43.

PMID:
8572661
[PubMed - indexed for MEDLINE]
14.

Proteomic analysis of inclusion body myositis.

Li J, Yin C, Okamoto H, Jaffe H, Oldfield EH, Zhuang Z, Vortmeyer AO, Rushing EJ.

J Neuropathol Exp Neurol. 2006 Aug;65(8):826-33.

PMID:
16896316
[PubMed - indexed for MEDLINE]
15.

Inflammatory, immune, and viral aspects of inclusion-body myositis.

Dalakas MC.

Neurology. 2006 Jan 24;66(2 Suppl 1):S33-8. Review.

PMID:
16432143
[PubMed - indexed for MEDLINE]
16.

Glucocorticoid-sensitive hereditary inclusion body myositis.

Naumann M, Reichmann H, Goebel HH, Moll C, Toyka KV.

J Neurol. 1996 Feb;243(2):126-30.

PMID:
8750548
[PubMed - indexed for MEDLINE]
17.

Messenger RNA degradation may be inhibited in sporadic inclusion body myositis.

Nakano S, Shinde A, Ito H, Ito H, Kusaka H.

Neurology. 2005 Aug 9;65(3):420-5.

PMID:
16087907
[PubMed - indexed for MEDLINE]
18.

Dermatomyositis with the features of inclusion body myositis associated with carcinoma of the bladder.

Talanin NY, Bushore D, Rasberry R, Rudolph T, Tuli M, Friedman-Musicante R.

Br J Dermatol. 1999 Nov;141(5):926-30.

PMID:
10583182
[PubMed - indexed for MEDLINE]
19.

Molecular pathology and pathogenesis of inclusion-body myositis.

Askanas V, Engel WK.

Microsc Res Tech. 2005 Jul;67(3-4):114-20. Review.

PMID:
16104000
[PubMed - indexed for MEDLINE]
20.

Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.

Askanas V, Engel WK.

Neurology. 2006 Jan 24;66(2 Suppl 1):S39-48. Review.

PMID:
16432144
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk